Intrinsic Value of S&P & Nasdaq Contact Us

Accolade, Inc. ACCD NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
40/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.03
+0.1%

Financial Health Score — ACCD

Accolade, Inc. (ACCD) has an overall financial health rating of C with a composite score of 0 out of 5.

This suggests the company faces some financial challenges worth monitoring. Rating as of 2025-04-07.

C
Overall Rating
2025-04-07

Rating History

Date Rating DCF ROE ROA D/E P/E P/B
2025-04-07 C -/5 -/5 -/5 -/5 -/5 -/5
2025-04-04 C -/5 -/5 -/5 -/5 -/5 -/5
2025-04-03 C -/5 -/5 -/5 -/5 -/5 -/5
2025-04-02 C -/5 -/5 -/5 -/5 -/5 -/5
2025-04-01 C -/5 -/5 -/5 -/5 -/5 -/5
2025-03-31 C -/5 -/5 -/5 -/5 -/5 -/5
2025-03-28 C -/5 -/5 -/5 -/5 -/5 -/5
2025-03-27 C -/5 -/5 -/5 -/5 -/5 -/5
2025-03-26 C -/5 -/5 -/5 -/5 -/5 -/5
2025-03-25 C -/5 -/5 -/5 -/5 -/5 -/5
2025-03-24 C -/5 -/5 -/5 -/5 -/5 -/5
2025-03-21 C -/5 -/5 -/5 -/5 -/5 -/5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message